Trials / Completed
CompletedNCT03103880
Assessing the Use of Mobile Technology in Adult Asthma Patients
Assessing the Use of Digital Therapeutic in Adult Asthma Patients: A Remote Observational Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 104 (actual)
- Sponsor
- CoheroHealth · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, remote observational study of adults with persistent asthma who are managed on inhaled corticosteroids.
Detailed description
The study consists of one interventional group and all 104 subjects will be included in this group. All subjects will be provided with the HeroTracker package, which includes: 1. HeroTracker sensor that counts dosage and monitors real-time medication adherence 2. BreatheSmart mobile application that sends subjects real-time alerts and allows patients respond to questionnaires / surveys.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | BreatheSmart | BreatheSmart is a comprehensive asthma monitoring system that combines a medical device and mobile application that are designed for use with Apple and Android mobile devices. The medical device connects to the mobile application using Bluetooth to facilitate the collection of controlled medication adherence, rescue medication usage, and asthma control. |
Timeline
- Start date
- 2017-04-21
- Primary completion
- 2018-08-29
- Completion
- 2018-08-29
- First posted
- 2017-04-06
- Last updated
- 2024-07-30
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03103880. Inclusion in this directory is not an endorsement.